Global 3D Bioprinting of Living Human Tissues/Organs Market is expected to foresee significant growth during the forecast period. North America to witness the highest growth

Global 3D Bioprinting of Living Human Tissues/Organs Market is expected to reach the market valuation of US$ 2,846.3 million by 2027 expanding at a reasonable CAGR of 20.75% during the forecast period (2021-2027) from US$ 651.6 million in 2019. The 3D Bioprinting of Living Human Tissues/Organs is an additive manufacturing technique that uses cells and other biocompatible materials that are also known as bioinks, to print tissue or living structures layer-by-layer which mimic the behavior of natural living systems.

For a detailed analysis of the 3D Bioprinting of Living Human Tissues/Organs browse through https://univdatos.com/report/global-3d-bioprinting-of-living-human-tissues-organs-market-current-analysis-and-forecast

The various factors driving the 3D Bioprinting of Living Human Tissues/Organs market include the surging demand for organ transplant owing to the rising prevalence of diseases that leads to the requirement of transplantation. As per the U.S Department of Health & Human Services, every 9 minutes, someone is added to the national transplant waiting list. Furthermore, the number of men, women, and children on the national transplant waiting list reached 109,000 as of September 2020. the limited number of organ donors globally is leading to the growth of the market.

For a detailed analysis of the market drivers in 3D Bioprinting of Living Human Tissues/Organs browse through https://univdatos.com/report/global-3d-bioprinting-of-living-human-tissues-organs-market-current-analysis-and-forecast

The growing demand for the transplant and rising aging population, the demand of 3D bio-printed living human tissue market is witnessing an uplift. In the United Kingdom, the average wait time for a liver is 4-5 months and 2.5-3 years for a kidney. Despite the acceleration, in 3D bioprinting research, The industry is still far from the completing requirements of printed organs for transplant.  However, the high cost of the 3D bioprinting of living human tissue is acting as a hinderer in the market growth. As per the studies, the current average costs of an organ transplant in the U.S. can escalate to well over US$ 1 million. However, the price is in decline mode every year. In 2015 the price for the 3D printed kidney was US$ 247,500 which is expected to decline and reach US$ 112,000 by 2030.

For a detailed analysis of the COVID-19 Impact on 3D Bioprinting of Living Human Tissues/Organs browse through https://univdatos.com/report/global-3d-bioprinting-of-living-human-tissues-organs-market-current-analysis-and-forecast

Based on Technology, the market is fragmented into inkjet printing, extrusion, laser-assisted bioprinting, and others. The extrusion segment dominated the market in 2019 accounted for 57.2% and is anticipated to maintain its dominance during the forecast period owing to its benefits such as the ability to fabricate designs with high cell densities, great flexibility in printing a wide range of bioinks, including tissue spheroids, cell pellets, microcarriers, decellularized matrix components. Also, it provides great versatility in printing various biological compounds or devices, including cells, Tissues/Organs, organoids, and microfluidic devices that are applied in basic research, pharmaceutics, drug testing, transplantation, and clinical uses.

For a detailed analysis of the applications in 3D Bioprinting of Living Human Tissues/Organs browse through https://univdatos.com/report/global-3d-bioprinting-of-living-human-tissues-organs-market-current-analysis-and-forecast

Based on the application, the market is mainly fragmented into research and clinical. The clinical segment dominated the market and accounted for 75.1% in 2019 and is anticipated to maintain its dominance during the analyzed period. Human Tissues/Organs such as bone, skin, and heart valves are usually removed from cadavers in hospitals, morgues, or even funeral homes and, unlike organs, can be stored sometimes for years in tissue banks. These Tissues/Organs can be used in numerous recipients as and when they are needed. In the early days of human tissue banking, not-for-profit banks, mostly located in hospitals, dominated the field.

However, 3D bioprinting has already been used for the generation and transplantation of several Tissues/Organs such as multilayered skin, bone, vascular grafts, tracheal splints, heart tissue, and cartilaginous structures for the research purpose. Therefore, the research segment would witness the highest CAGR of 22.4% during the forthcoming years.

For a detailed analysis of the tissues types in 3D Bioprinting of Living Human Tissues/Organs browse through https://univdatos.com/report/global-3d-bioprinting-of-living-human-tissues-organs-market-current-analysis-and-forecast

Based on the material, the market is mainly fragmented into Collagen, Gelatin, Alginate, Synthetic Macromolecules, Hyaluronic Acid, Generic Hydroge, and others. The collagen segment dominated the market and grabbed 16.2% in 2019. Moreover, the market is expected to witness growth with a CAGR of 22.6% during the forecast period on account of excellent biological properties such as biocompatibility and weak antigenicity. Moreover, collagen-based 3D Bio printed tissue has very high chances of clinical success in the future because collagen biomaterials have already been actively and successfully used in clinical practice for a long time.

Request for Sample of the report browse through https://univdatos.com/report/global-3d-bioprinting-of-living-human-tissues-organs-market-current-analysis-and-forecast

Additionally, the report provides detailed initiatives that are being taken in the field of 3D Bioprinting of Living Human Tissues/Organs. The market is classified into distinct regions including North America (the U.S and Canada), Europe (Germany, France, Spain, and United Kingdom), Asia-Pacific (China, Japan, Australia, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of US$ 235.4 million in 2019 owing to the limited number of organ donors and an increasingly aging population with chronic respiratory diseases. Rising R&D investment, technological advancement, and increasing incidence of chronic diseases.

Aspect Biosystems, BioBots (now Allevi), BioDan Group, BIOLIFE4D, Cellbrick, Cellink, Digilab, GeSiM, Microdrop Technologies, and MicroFab Technologies are some of the prominent players operating in the global 3D Bioprinting of Living Human Tissues/Organs market. Several M&As along with partnerships have been undertaken by these players to develop 3D Bioprinting of Living Human Tissues/Organs.

 

Global 3D Bioprinting of Living Human Tissues/Organs Market Segmentation

Market Insight, by Application

  • Research
  • Clinical

Market Insight, by Technology

  • Inkjet
  • Extrusion
  • Laser-Assisted Bioprinting
  • Others

Market Insight, by Material

  • Collagen
  • Gelatin
  • Alginate
  • Synthetic Macromolecules
  • Hyaluronic Acid
  • Generic Hydroge
  • Others

Market Insight, by Tissue Type

  • Generic Tissue / Organ
  • Renal
  • Skin
  • Bone
  • Liver
  • Lungs
  • Cardiac / Cardiovascular
  • Adipose Tissue
  • Cartilage
  • Ocular Tissue
  • Tumor Tissue
  • Others

Market Insight, by End-Users

  • Hospital
  • Research Organizations & Academic Institutes

Market Insight, by Region

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • France
    • Germany
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Rest of World

Top Company Profiles

  • Aspect Biosystems
  • BioBots (now Allevi)
  • BioDan Group
  • BIOLIFE4D
  • Cellbrick
  • Cellink
  • Digilab
  • GeSiM
  • Microdrop Technologies
  • MicroFab Technologies